| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/30/2002 | EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175489A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 01/30/2002 | EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/30/2002 | EP1175441A1 Neurite outgrowth and guidance by tenascin-c |
| 01/30/2002 | EP1175440A1 48 human secreted proteins |
| 01/30/2002 | EP1175439A1 49 human secreted proteins |
| 01/30/2002 | EP1175438A1 62 human secreted proteins |
| 01/30/2002 | EP1175436A2 Transiently immortalized cells for use in gene therapy |
| 01/30/2002 | EP1175432A1 Processes for the synthesis of oligomers using phusphoramidite compositions |
| 01/30/2002 | EP1175430A1 Antisense-oligos with better stability and antisense effect |
| 01/30/2002 | EP1175228A1 Gene therapy using tgf-beta |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP1175144A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/30/2002 | EP0888373A4 Smooth muscle cell lim protein |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0497922B1 Infective protein delivery system |
| 01/30/2002 | CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333829A Polypeptide |
| 01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
| 01/30/2002 | CN1333689A Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 01/30/2002 | CN1333678A Hepatocyte targeting polyethylene glyco-grafted poly-lysine polymeric gene carrier |
| 01/30/2002 | CN1333351A Novel polypeptide--human protein kinase 27.17 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333338A Papilloma pseudovirus and process for preparing same |
| 01/30/2002 | CN1333278A Novel polypeptide-human ribosomal protein L7a 20.57 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333233A Novel polypeptide--enkaryotic transcription factor 17.38 and polynucleotide for encoding said polypeptide |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342594 Determination of metastatic potential of cancer cells in test samples |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342390 Integration of dna into chromosome of cell; does not generate virus particles; genetic expression and engineering |
| 01/29/2002 | US6342372 Culture to form protein using nutrients, isolation, culture of cells for expression of recombitant protein |
| 01/29/2002 | US6342370 Amino acid seqences and polynucleotides |
| 01/29/2002 | US6342352 Method of detecting shigella and shigella mxiM DNA |
| 01/29/2002 | US6342234 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 01/29/2002 | US6342217 Radiation enhanced gene therapy for tumors expressing a gene for a viral pyrimidine kinase in the presence of a 5′-halogenated pyrimidine |
| 01/29/2002 | US6342216 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | US6342214 Method for viral vector delivery |
| 01/29/2002 | CA2223769C Method of treatment for asthma |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/24/2002 | WO2002006537A2 Methods of identifying renal protective factors |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006480A2 Tissue inhibitors of matrix metalloproteinases |
| 01/24/2002 | WO2002006479A2 Apoptosis-inducing dna sequences |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006454A2 Regulation of human carboxylesterase-like enzyme |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006451A1 Tissue-specific self-inactivating gene therapy vector |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006330A2 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006316A2 Alpha-msh related compounds and methods of use |
| 01/24/2002 | WO2002006315A2 Novel nucleic acid and amino acid sequences |
| 01/24/2002 | WO2002006297A1 Novel antisense oligonucleotide derivatives against wilms's tumor gene |
| 01/24/2002 | WO2002005864A1 An implantable or insertable therapeutic agent delivery device |
| 01/24/2002 | WO2002005857A2 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005840A1 Medicinal compositions for promoting fixation of transplanted cells |
| 01/24/2002 | WO2002005792A2 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 01/24/2002 | WO2002005749A2 Crf2 ligands in combination therapy |
| 01/24/2002 | WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 01/24/2002 | WO2001077152A3 Mammalian disulfide core protein-4 |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060794A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 01/24/2002 | WO2001059115A3 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 01/24/2002 | WO2001055324A3 Nucleic acids, proteins, and antibodies |
| 01/24/2002 | WO2001055212A3 Delivery of therapeutic biological from implantable tissue matrices |
| 01/24/2002 | WO2001054706A3 Method for treating kidney disorders |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001040258A3 Educational kit and method using tumor necrosis factor-stimulated gene and protein |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032711B1 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof |
| 01/24/2002 | WO2001027276A3 Dna sequences from breast tumor and uses thereof |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001015511A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2000073478A9 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | US20020010945 Kelch family of proteins and use thereof |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010144 Inserting wild-type therapy-sensitizing gene activity into tumor cells having mutant therapy-sensitizing gene activity and subjecting the tumor cells to a cancer therapy |
| 01/24/2002 | US20020009800 Genetically engineeered sequences for use in gene therapy of central nervous system |
| 01/24/2002 | US20020009771 G protein coupled receptor proteins, their production and use |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009431 Method for transplanting cells into the brain and therapeutic uses therefor |